Abstract
This study assessed the safety and efficacy of intravenous adenosine used as a coronary vasodilator in 18 pediatric patients with aortic valve disease or Kawasaki disease. Adenosine infusion effectively produced coronary vasodilation and was well tolerated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have